The Department of Pharmaceutics offers a program of study leading to the Doctor of Philosophy degree.
The doctoral degree program in pharmaceutics trains research scholars in the fundamental aspects of drug delivery, drug disposition, and drug action in animals and man. Drug disposition includes the facets of drug absorption, distribution, and elimination. Pharmacokinetics is the study of the time course of these processes and the time course of pharmacological effects. Drug delivery includes targeting of drugs and modulation of xenobiotic and drug transporters to tissues or specific cell types to improve their therapeutic effect. For further information, visit: sop.washington.edu/pharmaceutics/about/what-is-pharmaceutics.html.
Typically graduates interact with clinicians, medicinal chemists, biochemists, pharmacologists, analytical chemists, and physiologists.This is possible because their training is highly interdisciplinary at the didactic and research levels.
A wide range of career paths is available to graduates.Opportunities include research in the pharmaceutical industry; research in hospitals, institutes, and foundations; teaching and research in academic institutions; and positions with government regulatory agencies.
Graduate Program Coordinator
Doctor of Philosophy
Minimum 90 credits of coursework, to include:
Applicants with a PharmD degree should have fulfilled the medicinal chemistry requirement. MEDCH 400 can be taken in autumn quarter of the first year. Candidates are accepted on condition that any deficiencies in course requirements are rectified by the end of the first academic year.
Students entering with previous graduate-level course work in the required areas may have some of the above courses waived. In addition, all students must attend the following training sessions, preferably during the first academic year: chemical safety, biological safety, and bioethics training. Radiation safety and animal care may also be required, if relevant to the student's thesis research.
Electives are not required. However, students are encouraged to take elective courses that might benefit their thesis project and career goals. Courses that might be of interest can be found in the disciplines of biotransformation/biochemistry, biologics/drug delivery, pharmacology/cell biology, and physiological modeling/biostatistics.
Beginning the second year, students make one presentation each year, with a maximum of four presentations. A general topic seminar is presented in the second year; research presentations in subsequent years.
Beginning the second year, students make two presentations each year until graduation. Journal club presentation is waived in the quarter during which the student is scheduled to make a PCEUT 520 seminar presentation.
Students complete three research laboratory rotations (PCEUT 600, 2 credits), one per quarter, starting autumn quarter of their first year. A student may opt to complete a rotation in summer quarter, before the initiation of classes. This involves an early appointment in the department and, thus, decisions must be made at the time they accept the offer to enroll. Matching of available labs with each incoming student is facilitated by the first year graduate adviser. Student preferences are given due consideration.
Students must choose a thesis adviser by the end of spring quarter in their first academic year (See Appendix A for additional details).
Students must begin research in the lab of their adviser by summer quarter at the end of their first academic year (PCEUT 600, variable credit). Most students may find that after-class and off-hours are the best and most productive time for laboratory research (See Appendix A1b for additional details).
After successful completion of the master's bypass requirements (see Appendix A for details), students sign up for PCEUT 800 (variable credit), until the defense of their thesis.
Students begin taking cumulative exams in autumn quarter of their second academic year, and continue taking them at every offering until completion of pass requirements or until they take the maximum of eight exams. A total of eight exams are offered, two each in autumn, winter, spring, and summer quarters. For each exam, there two questions. Students must pass four of eight exams to complete the cumulative requirement. Students who do not achieve this goal are given the option of completing requirements for a terminal master's degree or withdrawal from the program.
All students in the program receive financial support in the form of research assistantships, Public Health Service predoctoral training fellowships, and other fellowships such as the William E. Bradley Graduate Fellowship or those from the American Foundation for Pharmaceutical Education or from several pharmaceutical companies.